YaTCM: Yet another Traditional Chinese Medicine Database for Drug Discovery
暂无分享,去创建一个
Chunfeng Ma | Xiaoyong Zhao | Jianping Lin | Baiqing Li | Zhigang Hu | Tengfei Du | Xuanming Xu | Zhonghua Wang | Chunfeng Ma | Jianping Lin | Tengfei Du | Baiqing Li | Xuanming Xu | Zhonghua Wang | Xiaoyong Zhao | Zhigang Hu
[1] Jun Li,et al. Anti-inflammatory and immunoregulatory effects of Yupingfeng (玉屏风) powder on chronic bronchitis rats , 2013, Chinese Journal of Integrative Medicine.
[2] X. Su,et al. Artemisinin: Discovery from the Chinese Herbal Garden , 2011, Cell.
[3] R. Teschke,et al. Review article: herbal hepatotoxicity – an update on traditional Chinese medicine preparations , 2014, Alimentary pharmacology & therapeutics.
[4] Y. Mo,et al. Cacalol, a natural sesquiterpene, induces apoptosis in breast cancer cells by modulating Akt-SREBP-FAS signaling pathway , 2011, Breast Cancer Research and Treatment.
[5] Hao Ye,et al. HIT: linking herbal active ingredients to targets , 2010, Nucleic Acids Res..
[6] Jian Huang,et al. CEMTDD: Chinese Ethnic Minority Traditional Drug Database , 2014, Apoptosis.
[7] Z. Wang,et al. PhIN: A Protein Pharmacology Interaction Network Database , 2015, CPT: pharmacometrics & systems pharmacology.
[8] Zhao Fang,et al. TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis , 2012, Nucleic Acids Res..
[9] J. Greef. Perspective: All systems go , 2011, Nature.
[10] John S. Delaney,et al. Assessing the ability of chemical similarity measures to discriminate between active and inactive compounds , 1996, Molecular Diversity.
[11] L. Ouyang,et al. CEMTDD: The database for elucidating the relationships among herbs, compounds, targets and related diseases for Chinese ethnic minority traditional drugs , 2015, Oncotarget.
[12] Thomas M. Ehrman,et al. Phytochemical Databases of Chinese Herbal Constituents and Bioactive Plant Compounds with Known Target Specificities. , 2007 .
[13] Calvin Yu-Chian Chen,et al. TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico , 2011, PloS one.
[14] Jun Li,et al. Total extract of Yupingfeng attenuates bleomycin-induced pulmonary fibrosis in rats. , 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[15] Jürgen Bajorath,et al. Polypharmacology Directed Compound Data Mining: Identification of Promiscuous Chemotypes with Different Activity Profiles and Comparison to Approved Drugs , 2010, J. Chem. Inf. Model..
[16] Ming-Wei Wang,et al. Biological screening of natural products and drug innovation in China , 2007, Philosophical Transactions of the Royal Society B: Biological Sciences.
[17] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[18] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[19] D. Kell,et al. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries. , 2009, Drug discovery today.
[20] Tingjun Hou,et al. A 3D Structure Database of Components from Chinese Traditional Medicinal Herbs , 2002, J. Chem. Inf. Comput. Sci..
[21] Jian-Guo Jiang,et al. Typical toxic components in traditional Chinese medicine , 2012, Expert opinion on drug safety.
[22] Strohl,et al. The role of natural products in a modern drug discovery program. , 2000, Drug discovery today.
[23] Xiaojie Xu,et al. CVDHD: a cardiovascular disease herbal database for drug discovery and network pharmacology , 2013, Journal of Cheminformatics.
[24] Pedro J. Ballester,et al. How Reliable Are Ligand-Centric Methods for Target Fishing? , 2015, bioRxiv.
[25] Brian K. Shoichet,et al. Chemical informatics uncovers a new role for moexipril as a novel inhibitor of cAMP phosphodiesterase-4 (PDE4) , 2013, Biochemical pharmacology.
[26] S. Bent,et al. Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation , 2008, Journal of General Internal Medicine.
[27] Peter Ertl,et al. JSME: a free molecule editor in JavaScript , 2013, Journal of Cheminformatics.
[28] See-Tong Pang,et al. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia , 2017, Science Translational Medicine.
[29] Minoru Kanehisa,et al. KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..
[30] Yicheng He,et al. Baicalin attenuates bleomycin-induced pulmonary fibrosis via adenosine A2a receptor related TGF-β1-induced ERK1/2 signaling pathway , 2016, BMC Pulmonary Medicine.
[31] M. Soares,et al. Antimalarial activity of physalins B, D, F, and G. , 2011, Journal of natural products.
[32] Zheng Yin,et al. Improving chemical similarity ensemble approach in target prediction , 2016, Journal of Cheminformatics.
[33] Jacques Cohen,et al. Bioinformatics—an introduction for computer scientists , 2004, CSUR.
[34] Noboru Fukuda,et al. Transforming growth factor-beta expression in cardiovascular organs in stroke-prone spontaneously hypertensive rats with the development of hypertension. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.
[35] Xue Xu,et al. Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. , 2013, Journal of ethnopharmacology.
[36] Wei Zhou,et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines , 2014, Journal of Cheminformatics.
[37] Shan Miao,et al. Cardioprotective Effect of Paeonol and Danshensu Combination on Isoproterenol-Induced Myocardial Injury in Rats , 2012, PloS one.
[38] S. Peng,et al. ERK in Learning and Memory: A Review of Recent Research , 2010, International journal of molecular sciences.
[39] Jae Yong Ryu,et al. A systems approach to traditional oriental medicine , 2015, Nature Biotechnology.
[40] Zhiguo Xu. Modernization: One step at a time , 2011, Nature.
[41] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[42] J. Lehár,et al. Multi-target therapeutics: when the whole is greater than the sum of the parts. , 2007, Drug discovery today.
[43] Brad T. Sherman,et al. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.
[44] Tingjun Hou,et al. Drug-likeness analysis of traditional Chinese medicines: prediction of drug-likeness using machine learning approaches. , 2012, Molecular pharmaceutics.
[45] Ilya Raskin,et al. Revisiting the ancient concept of botanical therapeutics. , 2007, Nature chemical biology.
[46] Thorsten Meinl,et al. KNIME: The Konstanz Information Miner , 2007, GfKl.
[47] L. Peshkin,et al. Exploiting polypharmacology for drug target deconvolution , 2014, Proceedings of the National Academy of Sciences.
[48] Kevan M. Shokat,et al. Chemical genetic discovery of targets and anti-targets for cancer polypharmacology , 2012, Nature.
[49] Hsin-Hsi Chen,et al. TCMGeneDIT: a database for associated traditional Chinese medicine, gene and disease information using text mining , 2008, BMC complementary and alternative medicine.
[50] Mathias Dunkel,et al. Super Natural II—a database of natural products , 2014, Nucleic Acids Res..
[51] Y. Tu. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine , 2011, Nature Medicine.
[52] X. Chen,et al. TTD: Therapeutic Target Database , 2002, Nucleic Acids Res..